Literature DB >> 27414255

Renal Clearable Organic Nanocarriers for Bioimaging and Drug Delivery.

Homan Kang1, Julien Gravier1,2,3, Kai Bao1, Hideyuki Wada1, Jeong Heon Lee1, Yoonji Baek1, Georges El Fakhri1, Sylvain Gioux1, Brian P Rubin4, Jean-Luc Coll5,6, Hak Soo Choi7.   

Abstract

Renally cleared zwitterionic nanocarriers (H-Dots) are composed of ε-polylysine backbone for charge variations, near-infrared fluorophores for bioimaging, and β-cyclodextrins for potential drug delivery. H-Dots show ideal systemic circulation and rapid distribution and excrete from normal tissue/organ via renal excretion after complete targeting to the tumor site without nonspecific uptake by the immune system.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug delivery; nanoparticles; optical imaging; renal clearance; theranostics

Mesh：

Substances：

Year:  2016        PMID： 27414255      PMCID： PMC5155334          DOI： 10.1002/adma.201601101

Source DB:  PubMed          Journal:  Adv Mater        ISSN： 0935-9648            Impact factor:   30.849


  31 in total

Review 1.  Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.

Authors:  Angiolo Gadducci; Stefania Cosio; Andrea Riccardo Genazzani
Journal:  Crit Rev Oncol Hematol       Date:  2006-01-24       Impact factor: 6.312

Review 2.  Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine.

Authors:  Michael W Ambrogio; Courtney R Thomas; Yan-Li Zhao; Jeffrey I Zink; J Fraser Stoddart
Journal:  Acc Chem Res       Date:  2011-06-15       Impact factor: 22.384

3.  Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.

Authors:  Szabolcs Béni; Zoltán Szakács; Orsolya Csernák; Lajos Barcza; Béla Noszál
Journal:  Eur J Pharm Sci       Date:  2006-11-07       Impact factor: 4.384

4.  Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.

Authors:  Evan Phillips; Oula Penate-Medina; Pat B Zanzonico; Richard D Carvajal; Pauliah Mohan; Yunpeng Ye; John Humm; Mithat Gönen; Hovanes Kalaigian; Heiko Schöder; H William Strauss; Steven M Larson; Ulrich Wiesner; Michelle S Bradbury
Journal:  Sci Transl Med       Date:  2014-10-29       Impact factor: 17.956

Review 5.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

6.  pH- and thermosensitive supramolecular assembling system: rapidly responsive properties of beta-cyclodextrin-conjugated poly(epsilon-lysine).

Authors:  Hak Soo Choi; Kang Moo Huh; Tooru Ooya; Nobuhiko Yui
Journal:  J Am Chem Soc       Date:  2003-05-28       Impact factor: 15.419

Review 7.  Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles.

Authors:  Homan Kang; Shrutika Mintri; Archita Venugopal Menon; Hea Yeon Lee; Hak Soo Choi; Jonghan Kim
Journal:  Nanoscale       Date:  2015-11-03       Impact factor: 7.790

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

9.  Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.

Authors:  Samuli Hirsjärvi; Sandrine Dufort; Julien Gravier; Isabelle Texier; Qiao Yan; Jérome Bibette; Lucie Sancey; Véronique Josserand; Catherine Passirani; Jean-Pierre Benoit; Jean-Luc Coll
Journal:  Nanomedicine       Date:  2012-09-06       Impact factor: 5.307

10.  Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.

Authors:  Joo Eun Chung; Susi Tan; Shu Jun Gao; Nunnarpas Yongvongsoontorn; Soon Hee Kim; Jeong Heon Lee; Hak Soo Choi; Hirohisa Yano; Lang Zhuo; Motoichi Kurisawa; Jackie Y Ying
Journal:  Nat Nanotechnol       Date:  2014-10-05       Impact factor: 39.213
View more
  35 in total

1.  Theranostic Nanosystems for Targeted Cancer Therapy.

Authors:  Homan Kang; Shuang Hu; Mi Hyeon Cho; Suk Ho Hong; Yongdoo Choi; Hak Soo Choi
Journal:  Nano Today       Date:  2018-11-16       Impact factor: 20.722

Review 2.  Near-Infrared-II Molecular Dyes for Cancer Imaging and Surgery.

Authors:  Shoujun Zhu; Rui Tian; Alexander L Antaris; Xiaoyuan Chen; Hongjie Dai
Journal:  Adv Mater       Date:  2019-04-26       Impact factor: 30.849

3.  Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors.

Authors:  Homan Kang; Wesley R Stiles; Yoonji Baek; Shinsuke Nomura; Kai Bao; Shuang Hu; G Kate Park; Min Joo Jo; Hoseok I; Jean-Luc Coll; Brian P Rubin; Hak Soo Choi
Journal:  Adv Mater       Date:  2019-12-18       Impact factor: 30.849

4.  High-resolution T1 MRI via renally clearable dextran nanoparticles with an iron oxide shell.

Authors:  Tae-Hyun Shin; Pan Ki Kim; Sunghwi Kang; Jiyong Cheong; Soojin Kim; Yongjun Lim; Wookjin Shin; Joon-Yong Jung; Jungsu D Lah; Byoung Wook Choi; Jinwoo Cheon
Journal:  Nat Biomed Eng       Date:  2021-03-08       Impact factor: 25.671

5.  Real-Time Imaging of Vaccine Biodistribution Using Zwitterionic NIR Nanoparticles.

Authors:  Wataru Katagiri; Jeong Heong Lee; Marc-André Tétrault; Homan Kang; Sinyoung Jeong; Conor L Evans; Shinya Yokomizo; Sheena Santos; Catherine Jones; Shuang Hu; Georges El Fakhri; Kosuke Tsukada; Hak Soo Choi; Satoshi Kashiwagi
Journal:  Adv Healthc Mater       Date:  2019-06-05       Impact factor: 9.933

6.  Chemical Modulation of Bioengineered Exosomes for Tissue-Specific Biodistribution.

Authors:  Do Won Hwang; Min Joo Jo; Jeong Heon Lee; Homan Kang; Kai Bao; Shuang Hu; Yoonji Baek; Hyung Geun Moon; Dong Soo Lee; Satoshi Kashiwagi; Maged Henary; Hak Soo Choi
Journal:  Adv Ther (Weinh)       Date:  2019-09-13

7.  Interactions of Renal-Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity Effects.

Authors:  Mengxiao Yu; Chen Zhou; Li Liu; Shanrong Zhang; Shasha Sun; Julia D Hankins; Xiankai Sun; Jie Zheng
Journal:  Angew Chem Int Ed Engl       Date:  2017-03-13       Impact factor: 15.336

Review 8.  Light-responsive nanomedicine for biophotonic imaging and targeted therapy.

Authors:  Jihwan Son; Gawon Yi; Jihye Yoo; Changhee Park; Heebeom Koo; Hak Soo Choi
Journal:  Adv Drug Deliv Rev       Date:  2018-10-12       Impact factor: 15.470

9.  Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates.

Authors:  Jing Xu; Mengxiao Yu; Chuanqi Peng; Phoebe Carter; Jia Tian; Xuhui Ning; Qinhan Zhou; Qiu Tu; Greg Zhang; Anthony Dao; Xingya Jiang; Payal Kapur; Jer-Tsong Hsieh; Xudong Zhao; Pengyu Liu; Jie Zheng
Journal:  Angew Chem Int Ed Engl       Date:  2017-12-05       Impact factor: 15.336

10.  Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting.

Authors:  Homan Kang; Sunghoon Rho; Wesley R Stiles; Shuang Hu; Yoonji Baek; Do Won Hwang; Satoshi Kashiwagi; Moon Suk Kim; Hak Soo Choi
Journal:  Adv Healthc Mater       Date:  2019-12-03       Impact factor: 9.933
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.